AuntMinnie

MARCH 5, 2025

It's been really neat for us to not only have the beneficial reuse, where we're offsetting the cost of the American taxpayer, but you're actually seeing something pretty cool come out of it in nuclear medicine space, explained OREM manager Jay Mullis. Canada, Australia, and in Europe. recently launched an effort similar to OREM's.

Nuclear Medicine 200

Nuclear Medicine Radiopharmaceuticals IT Clinic 200

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Nuclear Medicine 305

Nuclear Medicine Radiopharmaceuticals Imaging Medicare 305

Radiology Business

SEPTEMBER 11, 2023

The company has developed a portfolio of nuclear medicine solutions including "lead candidate" MC-339, used for treating small cell lung cancer.

Nuclear Medicine 263

Nuclear Medicine Radiopharmaceuticals 263

AuntMinnie

JANUARY 16, 2025

Oliverio joins Actineer with over 30 years of leadership experience across the nuclear medicine, medical device, and radiopharmaceutical industries, including roles at Ionetix, Imagin Molecular, and Positron.

Nuclear Medicine 130

Nuclear Medicine Medical Device Radiopharmaceuticals Medical 130

AuntMinnie

OCTOBER 14, 2024

The article was published October 10 in the Journal of Nuclear Medicine. These SSTRs can be targeted both with gallium-68 (Ga-68) imaging agents and therapeutic lutetium-177 (Lu-177) radiopharmaceuticals using a so-called theranostics approach. The full article is available here.

Nuclear Medicine 276

Nuclear Medicine Radiopharmaceuticals Insurance Clinic 276

AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclear medicine technologists means a theranostics center may need to limit its patient volume.

Nuclear Medicine 264

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 264

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 264

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 264

AuntMinnie

JULY 8, 2024

Nuclear medicine firm Curium has submitted a new drug application (NDA) for its lutetium-177 (Lu-177) DOTATATE radiopharmaceutical for treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETS).

Nuclear Medicine 243

Nuclear Medicine Radiopharmaceuticals Radiation IT 243

AuntMinnie

MAY 8, 2024

Theranostics treatments are used with increasing frequency now since the approvals and expansions of Lutathera (lutetium-177 [Lu-177]) DOTATATE, a radiopharmaceutical for neuroendrocrine tumors (NETs) and Pluvicto, Lu-177 PSMA-617, for prostate cancer.

Radiopharmaceuticals 189

Radiopharmaceuticals Nuclear Medicine Radiation Hospital 189

AuntMinnie

MARCH 7, 2024

In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. In 2023, 38% of PET systems were operated by the PET department, 28% by nuclear medicine, 24% by radiology/imaging, 5% by radiation oncology, and 2% by molecular imaging.

PET Scan 290

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 290

AuntMinnie

JUNE 9, 2024

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has bestowed its Georg Charles de Hevesy Nuclear Pioneer award on Carolyn Anderson, PhD, of the University of Missouri-Columbia (MU). The award honors those who have made outstanding contributions in the field of nuclear medicine, the SNMMI said.

Nuclear Medicine 246

Nuclear Medicine Radiopharmaceuticals Disease Imaging 246

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 306

AuntMinnie

JUNE 11, 2024

TORONTO – The radiopharmaceutical Pluvicto improves progression-free survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy, according to research presented at the SNMMI meeting. Oliver Sartor, MD The study, which was awarded SNMMI’s Abstract of the Year award, shared data from the phase III PSMAfore trial.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiographer Radiograph 306

AuntMinnie

JUNE 8, 2023

Radiopharmaceutical manufacturer SpectronRx and nuclear medicine drug distributo.

Radiopharmaceuticals 130

Radiopharmaceuticals Nuclear Medicine Clinic 130

AuntMinnie

OCTOBER 25, 2024

Louis, MO A first-time Minnies finalist, Dmitry Beyder exemplifies how the role of the nuclear medicine technologist can evolve. Beyder played a key role in launching the radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, BJH, and Siteman Cancer Center last year. Dmitry Beyder.

Nuclear Medicine 358

Nuclear Medicine Education Radiology Technologist Radiation Science 358

Open Medscience

JANUARY 1, 2024

Zirconium radiopharmaceuticals enhance nuclear medicine with precise diagnostics and potential therapeutic applications. The post Zirconium Radiopharmaceuticals in Nuclear Medicine appeared first on Open Medscience.

Nuclear Medicine 59

Nuclear Medicine Radiopharmaceuticals Diagnostic Medical 59

Open Medscience

NOVEMBER 11, 2023

Copper radiopharmaceuticals offer groundbreaking diagnostic and therapeutic applications, revolutionising nuclear medicine, particularly in oncology and cardiology. The post Exploring Copper Radiopharmaceuticals: Innovations and Applications in Nuclear Medicine appeared first on Open Medscience.

Nuclear Medicine 59

Nuclear Medicine Radiopharmaceuticals Diagnostic Medical 59

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. He also helped lead the theranostics conference at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 midwinter meeting. However, few freestanding theranostics centers exist today. Hope added.

Nuclear Medicine 222

Nuclear Medicine Radiation Oncology Nursing Radiation 222

AuntMinnie

AUGUST 12, 2024

SPECT/CT imaging can help manage patients undergoing radiopharmaceutical therapy (RPT) with Pluvicto for advanced prostate cancer, according to a study published August 8 in the Journal of Nuclear Medicine. A graphical abstract of the study.

Nuclear Medicine 260

Nuclear Medicine Bone Scan Disease Radiopharmaceuticals 260

Open Medscience

JULY 28, 2019

Radiopharmaceuticals are used in nuclear medicine for the application of medical imaging and therapy. The post Radiopharmaceuticals used in nuclear medicine appeared first on Open Medscience.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Medical Imaging Medical 52

AuntMinnie

MARCH 26, 2025

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) presented its 2025 Legislative Champion Award to Representatives Neal Dunn, MD, and Ami Bera, MD. Centers for Medicare and Medicaid (CMS) to update the Hospital Outpatient Prospective Payment System (HOPPS) in 2025 by unbundling radiopharmaceuticals.

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Medicare Diagnostic 130

AuntMinnie

JUNE 6, 2023

Nuclear medicine pharmacy network Radioisotope Life Sciences (RLS) has won.

Radiopharmaceuticals 130

Radiopharmaceuticals Nuclear Medicine Radiography Imaging 130

Open Medscience

MARCH 22, 2024

Nuclear medicine and the future of precise, personalised care in diagnosing and treating diseases. The post Nuclear Medicine at the Centre of Radiology and Radiopharmaceuticals appeared first on Open Medscience.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiology Disease 52

AuntMinnie

SEPTEMBER 25, 2024

Nuclear cardiologists could see significant reductions in Medicare reimbursements in 2025, according to a leading expert. Ultimately, there are “many unknowns” to be explored in the next few months – implications regarding the unknown cost of new diagnostic radiopharmaceuticals, for instance – and the ASNC is in continuing talks with the CMS.

Radiopharmaceuticals 162

Radiopharmaceuticals Nuclear Medicine Medicare Diagnostic 162

Diagnostic Imaging

JUNE 9, 2024

shared her perspective on a number of topics affecting nuclear medicine, ranging from isotope availability and reimbursement challenges for diagnostic radiopharmaceuticals to increasing patient interest in PET imaging. In a recent interview, Cathy Cutler, Ph.D.,

Nuclear Medicine 65

Nuclear Medicine Radiopharmaceuticals Diagnostic Imaging 65

AuntMinnie

NOVEMBER 4, 2024

reduction in average Medicare payment rates compared with 2024, the CMS has estimated there will be a 0% change to reimbursement for radiology, nuclear medicine, and radiation oncology. With this rule in place, the CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630.

Radiation Oncology 200

Radiation Oncology Nuclear Medicine Medicare Imaging 200

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Medicare 130

Medicare Nuclear Medicine Radiopharmaceuticals Imaging 130

AuntMinnie

JUNE 19, 2024

Voximetry now offers nuclear medicine dosimetry technology as a remote service, with its recent launch of RPT Dosimetry Clinical Services. Incorporating radiopharmaceutical therapy dosimetry typically requires advanced, in-house software, and a trained physics staff, Voximetry said.

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Clinic Imaging 130

AuntMinnie

NOVEMBER 12, 2024

Beyder played a key role in launching the radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, BJH, and Siteman Cancer Center last year. Department of Energy and project leader, the Society of Nuclear Medicine and Molecular Imaging, on the way forward to "really help the people in West Africa."

Radiologist 360

Radiologist Education Clinic Radiology 360

AuntMinnie

JUNE 26, 2023

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Intersocieta.

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Imaging 130

Open Medscience

AUGUST 25, 2024

The article explores the theranostic applications of Terbium radionuclides, highlighting their diagnostic and therapeutic potential in nuclear medicine. The post Terbium Radionuclides for Theranostic Applications in Nuclear Medicine appeared first on Open MedScience.

Nuclear Medicine 59

Nuclear Medicine Diagnostic Radiopharmaceuticals 59

Imaging Technology

JANUARY 5, 2024

This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb). milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc.

Radiopharmaceuticals 104

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 104

Imaging Technology

JUNE 10, 2024

Anderson , PhD, a trailblazer in nuclear medicine, has been named the 2024 recipient of the Georg Charles de Hevesy Nuclear Pioneer Award. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2024 Annual Meeting, June 8-11 in Toronto.

Nuclear Medicine 104

Nuclear Medicine Radiopharmaceuticals Disease Imaging 104

AuntMinnie

FEBRUARY 7, 2024

The facility will include cleanrooms and analytical and microbiological labs necessary for high-volume production of lutetium-177 and terbium-161 isotopes, which are used in targeted nuclear medicine therapies for cancer patients.

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Medical IT 130

AuntMinnie

JUNE 10, 2024

A new AI PET/CT tool can assess patient cancer risk, predict tumor response, and estimate survival, according to research findings delivered June 10 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Toronto.

Nuclear Medicine 257

Nuclear Medicine Radiopharmaceuticals Imaging Medical Imaging 257

AuntMinnie

JUNE 14, 2024

Nuclear medicine injection extravasations and medical events will be the focus of the Advisory Committee on the Medical Uses of Isotopes (ACMUI)'s public teleconference on June 17. Nuclear Regulatory Commission (NRC) rulemaking. That might do away with diagnostic concerns, Flannery noted.

Nuclear Medicine 130

Nuclear Medicine Radiation Radiopharmaceuticals Medical 130

Open Medscience

JANUARY 24, 2024

Thorium-227 emerges in nuclear medicine, revolutionizing cancer treatment through precise, effective radiotheranostic and therapeutic applications. The post The Breakthrough Role of Thorium-227 in Theranostic Radiopharmaceuticals appeared first on Open Medscience.

Radiopharmaceuticals 64

Radiopharmaceuticals Nuclear Medicine 64